Clinical Trial Update: Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) [Phase 2]

View source ↗

Summary

The Phase 2 safety and efficacy trial of PN2034 in Type 2 Diabetes patients on rosiglitazone and metformin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PN2034
• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: Wellstat Therapeutics | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED